Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Columbia will award the 2015 Horwitz Prize to S. Lawrence Zipursky, for discovering a molecular identification system that helps neurons to wire the brain.
Researchers have discovered why long-term use of levodopa treatment commonly leads to a side effect that can be as debilitating as Parkinson’s disease itself.
Biogen, the ALS Association, and Columbia University Medical Center have announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease.
Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
People with autism have a wide range of symptoms, with no two people sharing the exact type and severity of behaviors. Now a large-scale analysis of hundreds of patients and nearly 1000 genes has started to uncover how diversity among traits can be traced to differences in patients’ genetic mutations.
Dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults, according to a study led by CUMC scientists.